Blood CX3CL1 levels are reportedly higher level in MCI than in controls, with MCI patients exhibiting over twice the CX3CL1 levels compared to controls and a 13% lower level of CX3CL1 in AD compared to MCI (Zhou et al., 2023). This evidence concerns the gene CX3CL1 and Alzheimer disease.